West Pharmaceutical Services | WST - Operating Profit


West Pharmaceutical Services reported $179.1M in Operating Profit for its fiscal quarter ending in June of 2026.





Operating Profit Change Date
Align Technology USD 191.32M 13.27M Jun/2026
Baxter International USD 276M 210M Jun/2026
Becton, Dickinson and Co. USD 752M 125M Jun/2026
Cerus USD -1.45M 488K Dec/2024
Charles River Laboratories USD 119.89M 9K Jun/2026
Cooper Companies USD -31M 243.8M Mar/2026
Dentsply International USD 84M 52M Jun/2026
Haemonetics USD 57.46M 5.12M Jun/2026
ICU Medical USD 60.43M 30.05M Jun/2026
Insulet USD 129.7M 7.7M Jun/2026
Integra LifeSciences USD 41.29M 29.82M Jun/2026
IQVIA Holdings USD 2.6B 2.03B Jun/2026
J&J USD 7.48B 860M Jun/2026
Medtronic USD 2.09B 354M Mar/2026
Merit Medical Systems USD 60.4M 16.25M Jun/2026
Neogen USD 3.1M 6.4M Mar/2026
OraSure Technologies USD -13.59M 2.13M Dec/2025
Quidel USD -15.3M 16.5M Jun/2026
Repligen USD 21.13M 1.15M Jun/2026
Rockwell Medical USD 515K 1.84M Jun/2024
Solventum Corp USD 181M 96M Jun/2026
STAAR Surgical USD 10.1M 7.3M Jun/2026
Terumo JPY 89.48B 58.03B Jun/2026
Utah Medical Products USD 2.56M 124K Mar/2026
West Pharmaceutical Services USD 179.1M 2M Jun/2026